National Health Investors (NHI) Liabilities and Shareholders Equity (2009 - 2026)

National Health Investors' Liabilities and Shareholders Equity history runs 18 years deep, the most recent figure standing at $2.9 billion for Q1 2026.

• Quarterly Liabilities and Shareholders Equity rose 3.84% year-over-year to $2.9 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.1 billion (up 7.15% YoY) and the FY2025 annual result came in at $2.8 billion, up 6.98% from the prior year.
• Liabilities and Shareholders Equity was $2.9 billion for Q1 2026 at National Health Investors, up from $2.8 billion in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $2.9 billion in Q1 2026 and bottomed at $2.5 billion in Q3 2024.
• A 5-year average of $2.6 billion and a median of $2.5 billion in 2023 frame the typical range for Liabilities and Shareholders Equity.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity slipped 15.93% — and 2025, when it climbed 12.3%.
• National Health Investors' Liabilities and Shareholders Equity stood at $2.5 billion in 2022, then dropped by 0.76% to $2.5 billion in 2023, then grew by 5.06% to $2.6 billion in 2024, then advanced by 6.98% to $2.8 billion in 2025, then increased by 3.32% to $2.9 billion in 2026.
• Business Quant data shows NHI's Liabilities and Shareholders Equity at $2.9 billion in Q1 2026, $2.8 billion in Q4 2025, and $2.7 billion in Q3 2025.